Status:
RECRUITING
Strokectomy in Malignant Cerebral Media Infarction
Lead Sponsor:
University of Rostock
Conditions:
Stroke, Ischemic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Decompressive hemicraniectomy (DC) is the standard procedure and life saving measure in case of malignant middle cerebral artery (MCA) infarction. However, there have been several studies reporting th...
Detailed Description
Ischemic stroke is one of the leading causes of disability and death worldwide. While cerebral middle cerebral artery (MCA) infarction constitutes approximately 10% of all ischemic, it is a life-threa...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Ischemic middle cerebral artery (MCA) infarction at least two thirds of the MCA territory
- Clinical symptoms of acute unilateral MCA infarction less than 48 hours prior to the initiation of treatment
Exclusion
- Preexisting modified Rankin Scale \>2
- Absence of pupillary reflexes or GCS \<6
- Intracerebral hemorrhage or other associated brain lesions
- Contraindications for surgery
- Estimated life expectancy of less than 3 years
Key Trial Info
Start Date :
June 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06489470
Start Date
June 15 2024
End Date
June 30 2025
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Rostock
Rostock, Mecklenburg-Vorpommern, Germany, 18057